Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
MMWR Morb Mortal Wkly Rep ; 73(13): 278-285, 2024 Apr 04.
Artigo em Inglês | MEDLINE | ID: mdl-38573841

RESUMO

The reliable and timely detection of poliovirus cases through surveillance for acute flaccid paralysis (AFP), supplemented by environmental surveillance of sewage samples, is a critical component of the polio eradication program. Since 1988, the number of polio cases caused by wild poliovirus (WPV) has declined by >99.9%, and eradication of WPV serotypes 2 and 3 has been certified; only serotype 1 (WPV1) continues to circulate, and transmission remains endemic in Afghanistan and Pakistan. This surveillance update evaluated indicators from AFP surveillance, environmental surveillance for polioviruses, and Global Polio Laboratory Network performance data provided by 28 priority countries for the program during 2022-2023. No WPV1 cases have been detected outside of Afghanistan and Pakistan since August 2022, when an importation into Malawi and Mozambique resulted in an outbreak during 2021-2022. During 2022-2023, among 28 priority countries, 20 (71.4%) met national AFP surveillance indicator targets, and the number of environmental surveillance sites increased. However, low national rates of reported AFP cases in priority countries in 2023 might have resulted from surveillance reporting lags; substantial national and subnational AFP surveillance gaps persist. Maintaining high-quality surveillance is critical to achieving the goal of global polio eradication. Monitoring surveillance indicators is important to identifying gaps and guiding surveillance-strengthening activities, particularly in countries at high risk for poliovirus circulation.


Assuntos
Enterovirus , Poliomielite , Poliovirus , Humanos , alfa-Fetoproteínas , Saúde Global , Vigilância da População/métodos , Erradicação de Doenças , Poliomielite/epidemiologia , Poliomielite/prevenção & controle , Poliomielite/diagnóstico , Programas de Imunização
2.
MMWR Morb Mortal Wkly Rep ; 72(23): 613-620, 2023 Jun 09.
Artigo em Inglês | MEDLINE | ID: mdl-37289657

RESUMO

Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of wild poliovirus (WPV) cases has declined by >99.9%, and WPV serotypes 2 and 3 have been declared eradicated (1). By the end of 2022, WPV type 1 (WPV1) transmission remained endemic only in Afghanistan and Pakistan (2,3). However, during 2021-2022, Malawi and Mozambique reported nine WPV1 cases that were genetically linked to Pakistan (4,5), and circulating vaccine-derived poliovirus (cVDPV) outbreaks were detected in 42 countries (6). cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity allowing reversion to neurovirulence and can cause paralysis. Polioviruses are detected primarily through surveillance for acute flaccid paralysis (AFP), and poliovirus is confirmed through stool specimen testing. Environmental surveillance, the systematic sampling of sewage and testing for the presence of poliovirus, supplements AFP surveillance. Both surveillance systems were affected by the COVID-19 pandemic's effects on public health activities during 2020 (7,8) but improved in 2021 (9). This report updates previous reports (7,9) to describe surveillance performance during 2021-2022 in 34 priority countries.* In 2022, a total of 26 (76.5%) priority countries met the two key AFP surveillance performance indicator targets nationally compared with 24 (70.6%) countries in 2021; however, substantial gaps remain in subnational areas. Environmental surveillance expanded to 725 sites in priority countries, a 31.1% increase from the 553 sites reported in 2021. High-quality surveillance is critical to rapidly detect poliovirus transmission and enable prompt poliovirus outbreak response to stop circulation. Frequent monitoring of surveillance guides improvements to achieve progress toward polio eradication.


Assuntos
COVID-19 , Enterovirus , Poliomielite , Poliovirus , Humanos , Pandemias , alfa-Fetoproteínas , Erradicação de Doenças , Vigilância da População , Saúde Global , COVID-19/epidemiologia , Poliomielite/epidemiologia , Poliomielite/prevenção & controle , Poliomielite/diagnóstico , Poliovirus/genética , Vacina Antipólio Oral , Surtos de Doenças/prevenção & controle , Programas de Imunização
3.
Vaccine ; 39(15): 2124-2132, 2021 04 08.
Artigo em Inglês | MEDLINE | ID: mdl-33736917

RESUMO

BACKGROUND: Stopping serotype 1 wild poliovirus transmission in Pakistan and Afghanistan requires ensuring all children <5 years of age are repeatedly vaccinated, including the large proportion living in mobile groups. Vaccinating children living in high-risk mobile populations (HRMPs) remains a priority for the polio programme. METHODS: In 2017-2018, group-level censuses were conducted in 43 districts of Pakistan, gathering information for all HRMP children <5 years of age residing in settlements. Demographic and mobility information was collected, including HRMP type, ethnicity, language, mode of transportation and movement patterns. Vaccination status was recorded for the most recent polio campaign. Proportion of HRMP children by demographic factors and mode of transportation was determined and the magnitude of movement was quantified based on the origin, previous and next locations. Magnitude of cross-border movement with Afghanistan was evaluated, as was primary crossing point. Vaccination status was evaluated for each district by demographic and mode of transportation information. RESULTS: In total, 188,130 HRMP children <5 years of age were assessed. The predominant HRMP type, ethnic group, language and mode of transport was Afghan refugees (27%), Pashtun (69%), Pashto (69%) and bus (52%). Overall, 84% of children originated outside of their current district, including 29% from Afghanistan. Previous and next locations, were reported outside of current location by 34% and 77% of children. Afghanistan was previous and next location for 5% and 11% of children, with 5.5% and 3% of children crossing the Afghanistan border in the past 6-months and next 3-months. Primary crossing route was Torkham (79%). Overall vaccination coverage was 98% (IQR: 96%-99%) and consistently >90% across HRMP type, ethnic group, language and mobility means. CONCLUSION: Large numbers of HRMPs were found across Pakistan, with substantial links throughout the country and with Afghanistan. While vaccination coverage of HRMPs was high, ensuring these populations are consistently vaccinated remains a priority.


Assuntos
Poliomielite , Poliovirus , Afeganistão/epidemiologia , Criança , Humanos , Programas de Imunização , Lactente , Paquistão/epidemiologia , Poliomielite/epidemiologia , Poliomielite/prevenção & controle , Vacina Antipólio Oral , Vacinação
4.
East Mediterr Health J ; 26(5): 556-564, 2020 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-32538449

RESUMO

BACKGROUND: Counterfeit medicines are a threat to public health and the national economy in Egypt. The many community pharmacists in the country could help prevent counterfeit medicines reaching the patient. Information on community pharmacists' perceptions of counterfeit medicines is lacking. AIMS: This study assessed the awareness, practices and perceptions of community pharmacists in Alexandria, Egypt with regard to counterfeit medicines. The aim was to identify gaps and inadequacies in pharmacy practice that might allow infiltration of counterfeit medicines in the legitimate medicine supply chain. METHODS: A cross-sectional study was conducted of 175 community pharmacists in Alexandria in 2014-2015. A semi-structured interview questionnaire was used to assess their perceptions, awareness and practices. The chi-squared test was used to assess the relationships between selected pharmacists' characteristics and their awareness, purchasing practice and training related to counterfeit medicines. RESULTS: Most pharmacists thought medicine counterfeiting was widespread in Egypt and that they could contribute to combatting the problem. However, most also lacked a clear perception of counterfeit medicines, an awareness of their danger to patients or the legislation to reduce them. Their procurement practices and detection of counterfeit medicines and handling of incidents of counterfeit medicines were inadequate. Pharmacists who thought counterfeit medicines were widespread or a health threat were significantly more likely to purchase medicines from certified sources (P < 0.05). CONCLUSION: Pharmacists should be developed as a frontline resource to combat counterfeit medicines. To enhance their role, the pharmacy curriculum needs to be updated and continuing professional development activities mandated.


Assuntos
Medicamentos Falsificados , Farmacêuticos/estatística & dados numéricos , Adulto , Atitude do Pessoal de Saúde , Estudos Transversais , Egito , Feminino , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Masculino , Farmacêuticos/psicologia , Inquéritos e Questionários
5.
Vaccine ; 38(28): 4399-4404, 2020 06 09.
Artigo em Inglês | MEDLINE | ID: mdl-32402754

RESUMO

Pakistan is one of two countries in which poliovirus remains endemic. Considering the high number of children born every year, reaching and vaccinating new birth cohorts by improving routine immunization coverage in children <1 year of age is crucial to halting virus transmission. In 2015, a community-based vaccination (CBV) strategy, using local community members to enhance vaccine acceptance and improve routine immunization service delivery, was introduced in areas of Pakistan that have never interrupted poliovirus transmission. In order to assess progress towards improving routine immunization, we performed house-to-house immunization surveys across ten CBV areas in 2017 and 2018. In each household, we determined age-appropriate routine antigen coverage for children <1 year of age based on vaccination card and caregiver recall. We surveyed 5,499 and 5,264 children in 2017 and 2018, respectively. Overall, coverage of inactivated poliovirus vaccine (IPV) at 14 weeks of age was 32% in 2017 and 39% in 2018 based on vaccination card and recall. Across the surveyed areas, coverage ranged from 7% in Killa Abdullah to 61% in Peshawar in 2018. Oral poliovirus vaccination coverage decreased with successive vaccination visits, ranging from 66% for the birth dose to 42% for the 14-week dose in 2018. No area reached the target of 80% coverage for any routine antigen. Our findings highlight the need for concerted efforts to improve routine immunization coverage in these critical areas of wild poliovirus transmission.


Assuntos
Poliomielite , Cobertura Vacinal , Criança , Humanos , Programas de Imunização , Esquemas de Imunização , Lactente , Paquistão , Poliomielite/epidemiologia , Poliomielite/prevenção & controle , Vacina Antipólio de Vírus Inativado , Vacina Antipólio Oral , Vacinação
6.
Int J Pharm Pract ; 19(1): 13-20, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21235655

RESUMO

OBJECTIVES: This study sought to identify patients' perceived drug knowledge, need for more information and drug information sources, and how they varied by patient characteristics, particularly education level. METHODS: A convenience sample of 366 adult patients was interviewed when leaving 20 Egyptian pharmacies after collecting a dispensed prescription. Patients were asked about their (1) perceived knowledge of their drugs' purpose, (2) use of package inserts (PIs) to learn about side effects, contraindications and drug interactions, (3) perceived need to know more about their drugs and (4) general sources of drug information beyond healthcare providers. KEY FINDINGS: More than 30% of the patients reported that they did not know the purpose of at least one of their drugs and only read PIs selectively. Whereas 36% read about drug interactions, more reported reading about side effects (65%) and contraindications (60%) in PIs. Sixty-nine per cent of patients reported that they needed more information about their drugs. This was true for 86.8% of patients with limited education compared to 48.5% of university graduates. University graduates reported using PI topics, newspapers, internet, TV and family and friends as sources of drug information at significantly higher rates than did patients with lower levels of education. CONCLUSION: There is a need for healthcare professionals to evaluate patient comprehension and needs for drug information, especially for patients with less schooling. Healthcare providers should also consider other information sources that a patient is using.


Assuntos
Serviços de Informação sobre Medicamentos , Rotulagem de Medicamentos , Adulto , Idoso , Doença Crônica , Estudos Transversais , Egito , Feminino , Letramento em Saúde , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...